Twelve Hours of Sustained Ventricular Fibrillation Supported by a Continuous‐Flow Left Ventricular Assist Device

Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end‐stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous‐flow LVADs have become the preferred LVAD technology. As presented here, a continuous‐flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous‐flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation. (PACE 2012; 35:e144–e148)

[1]  L. Allen,et al.  Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  S. Russell,et al.  Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  S. Russell,et al.  Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. , 2010, Journal of the American College of Cardiology.

[4]  L. Allen,et al.  Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads. , 2010, Journal of cardiac failure.

[5]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[6]  S. Boesgaard,et al.  Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  P. Macdonald,et al.  Left Ventricular Mechanical Assist Devices and Cardiac Device Interactions: An Observational Case Series , 2009, Pacing and clinical electrophysiology : PACE.

[8]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[9]  H. Schima,et al.  Suction events during left ventricular support and ventricular arrhythmias. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  Yoshifumi Naka,et al.  Effects of left ventricular assist device therapy on ventricular arrhythmias. , 2005, Journal of the American College of Cardiology.

[11]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[12]  M. Lachat,et al.  Left ventricular assist device (LVAD) enables survival during 7 h of sustained ventricular fibrillation. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[14]  M. Oz,et al.  Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. , 1994, Journal of the American College of Cardiology.